Latest round

Series B

Last raised

Sep 2020

Total raised

$77M

Investors

7

About MEDx

Established in 2013 and based in Suzhou, China, MEDx is a translational medicine service platform that provides biomarker discovery, validation, molecular detection and inclusion screening of patients in clinical trials of new drugs, detection method development, etc. As of 2023, this company has more than 200 pharmaceutical customers and more than 200 biomarker discovery and detection methods. The company focuses on providing one-stop services ranging from biomarker discovery and assay development, to patient molecular testing and enrollment screening for clinical trials of new drugs, as well as companion diagnostic kit development and commercialization.

Who invested in MEDx

7 investors across 2 rounds

See all investors in MEDx

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 28, 2020

    Amount

    $52M

    Investors

    Locked

  2. Series A

    Jun 30, 2017

    Amount

    $26M

    Investors

    Locked

Questions about MEDx

Who invested in MEDx?

MEDx has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has MEDx raised?

MEDx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did MEDx last raise money?

MEDx's most recent round on record is a Series B, in Sep 2020.

What does MEDx do?

Established in 2013 and based in Suzhou, China, MEDx is a translational medicine service platform that provides biomarker discovery, validation, molecular detection and inclusion screening of patients in clinical trials of new drugs, detection method development, etc.

Where is MEDx headquartered?

MEDx is headquartered in Suzhou, China.

Which VCs invest in companies like MEDx?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at MEDx's stage. Their profiles are linked below.

Raising like MEDx? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.